PressNovember 16, 2020 MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities
PressNovember 13, 2020 Entheon Biomedical Corp. Commences Trading on the Canadian Securities Exchange
PressNovember 12, 2020 NeonMind Obtains Health Canada Approval to Advance Psilocybin Research – Better Plant Sciences
PressNovember 12, 2020 European synthetic biology company Octarine raises $1.8M USD in funding and enters pre-clinical studies with novel-improved- cannabinoid and psychedelic derivatives
PressNovember 10, 2020 Red Light Holland to Acquire Wholesale Distribution Company in the Netherlands Providing Access to over 1,000 Retail Outlets in Multiple EU Countries
PressNovember 10, 2020 Mind Cure Announces Hiring of Award-Winning Experimental Scientist Dr. Ryan Hartwell as Chief Science Officer
PressNovember 9, 2020 COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care
InterviewsNovember 6, 2020 Havn Life Sciences: Supplying the Compounds to Support the Future of Psychedelic Medicine
Market ResearchNovember 5, 2020 What Decriminalization in Oregon and DC Means for Psychedelic Investors
PressNovember 5, 2020 Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Signs Psilocybin Manufacturing Agreement
Market ResearchNovember 4, 2020 Mapping Psilocybin Reform: How This Years Election Is Making History [Infographic]
PressNovember 2, 2020 MindMed Announces the Completion of Phase 1 Study Measuring Dosing Effects of LSD
